Treatment | Concentration | n | Percentage of control | S.E.M. |
---|---|---|---|---|
% | ||||
Control | 22 | 100.0 | 7.5 | |
Flumazenil | 30 μM | 11 | 8.21-a | 1.0 |
Triazolam | 1 nM | 10 | 83.5 | 3.5 |
3 nM | 10 | 71.41-a | 3.1 | |
9 nM | 10 | 39.61-a | 2.3 | |
Ketoconazole | 1 μM | 12 | 58.21-a | 1.9 |
3 μM | 6 | 31.41-a | 2.0 | |
9 μM | 6 | 10.71-a | 3.5 | |
Itraconazole | 1 μM | 6 | 68.11-a | 6.7 |
3 μM | 6 | 86.9 | 8.1 | |
9 μM | 6 | 65.71-a | 11.4 | |
Buspirone | 1 μM | 6 | 77.5 | 9.8 |
3 μM | 6 | 94.7 | 7.4 | |
9 μM | 6 | 88.8 | 10.1 | |
Dizocilpine | 1 μM | 6 | 87.4 | 9.1 |
3 μM | 6 | 87.7 | 7.9 | |
9 μM | 6 | 86.8 | 8.8 | |
Paroxetine | 1 μM | 6 | 70.41-a | 9.5 |
3 μM | 6 | 69.31-a | 5.2 | |
9 μM | 6 | 64.41-a | 9.6 |
Data represent mean displacement of specific [3H]flunitrazepam binding to mouse brain cortical synaptosomes expressed as a percentage of control binding within each assay. n represents the number of individual assays performed, each in triplicate. Control values were calculated as follows: total specific binding values (pmol/mg) from all assays were averaged and total specific binding values (pmol/mg) from each individual assay were expressed as a percentage of the total mean.
↵1-a P < .05, significant differences from control as determined by ANOVA and Dunnett’s post hoc test.